Alumis ALMS
NASDAQ ALMS
$6.74 +0.04 (+0.60%)
As of: Oct 21, 2026 · 10:13 AM EDT

Alumis (ALMS) EBIT (2023 - 2026)

Updated

Alumis (ALMS) posted EBIT of -$148.86 million for Q2 2026, compared with -$140.54 million a year earlier.

Analysis

Alumis (ALMS) EBIT (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT at Alumis was -$501.13 million; for FY2025, it was -$453.8 million.

  • In prior years, Alumis' EBIT was -$300.75 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly EBIT in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,130.97 Bn 1,099.55 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 614.97 Bn 533.50 Bn 17.26 Bn 7.14 Bn
3 AbbVie 505.56 Bn 478.67 Bn 12.70 Bn 6.43 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.80 Bn 261.79 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.62 Bn 235.31 Bn 12.86 Bn 3.16 Bn
7 Amgen 235.78 Bn 191.18 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 189.91 Bn 164.11 Bn 6.22 Bn -10.39 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.27 Bn
10 Alumis 861.97 Mn -812.87 Mn - -148.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.86 Mn
Dec 31, 2025 -96.45 Mn
Sep 30, 2025 -115.29 Mn
Jun 30, 2025 -140.54 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -98.62 Mn
Sep 30, 2024 -98.40 Mn
Jun 30, 2024 -56.14 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -37.62 Mn
API Access

Alumis EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ALMS&period=max&api_key=YOUR_API_KEY